Home / Japan / JCR Pharmaceuticals Co.,Ltd.
JCR Pharmaceuticals Co.,Ltd.
Short position disclosed on October 5, 2026.
2.82% of the capital sold short
2 disclosing funds
47 disclosures on record
Evolution of the disclosed total
0%2%4%6%
Aug 16Aug 29Sep 11Sep 24Oct 7
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Barclays Capital Securities Ltd | 1.58% | +0.89 pt | October 5, 2026 | |
| Goldman Sachs International | 1.24% | new | October 5, 2026 |
Get the moves on JCR Pharmaceuticals Co.,Ltd. by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
Download 47 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- iFreeETF TOPIX Inverse (-1x) Index 45.50% of the capital sold short
- Towa Corporation 14.12% of the capital sold short
- Datasection Inc. 12.93% of the capital sold short
- KLab Inc. 10.57% of the capital sold short
- 3-D Matrix,Ltd. 10.28% of the capital sold short
- Nissan Motor Co.,ltd. 10.21% of the capital sold short
- SHIFT Inc. 10.16% of the capital sold short
- Unitika LTD. 9.65% of the capital sold short
- Terra Drone Corporation 9.63% of the capital sold short
- QD Laser,Inc. 9.31% of the capital sold short
- ReYuu Japan Inc. 9.09% of the capital sold short
- Hokkaido Electric Power Company,Incorporated 8.91% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, JCR Pharmaceuticals Co.,Ltd., source JPX, data as at October 5, 2026, https://www.quivad.com/action/jcr-pharmaceuticals-co-ltd